{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T20:30:28Z","timestamp":1722889828418},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,11,13]],"date-time":"2014-11-13T00:00:00Z","timestamp":1415836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s11033-014-3814-1","type":"journal-article","created":{"date-parts":[[2014,11,14]],"date-time":"2014-11-14T18:03:10Z","timestamp":1415988190000},"page":"673-679","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Frequency of interleukin 28B rs12979860 C>T variants in Filipino patients chronically infected with hepatitis B virus"],"prefix":"10.1007","volume":"42","author":[{"name":"The St. Luke\u2019s Liver Diseases Study Group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael O.","family":"Baclig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen G.","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia A.","family":"Mapua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliet","family":"Gopez-Cervantes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filipinas F.","family":"Natividad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,13]]},"reference":[{"key":"3814_CR1","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jcv.2004.10.009","volume":"32","author":"SJ Bell","year":"2005","unstructured":"Bell SJ, Lau A, Thompson A, Watson KJ, Demediuk B, Shaw G, Chen RY, Ayres A, Yuen L, Bartholomeusz A, Locarnini SA, Desmond PV (2005) Chronic hepatitis B: recommendations for therapy based on the natural history of disease in Australian patients. J Clin Virol 32:122\u2013127","journal-title":"J Clin Virol"},{"key":"3814_CR2","doi-asserted-by":"crossref","first-page":"e58071","DOI":"10.1371\/journal.pone.0058071","volume":"8","author":"IC Lee","year":"2013","unstructured":"Lee IC, Lin CH, Huang YH, Huo TI, Su CW, Hou MC, Huang HC, Lee KC, Chan CC, Lin MW, Lin HC, Lee SD (2013) IL28B polymorphism correlates with active hepatitis in patients with HBeAg-negative chronic hepatitis B. PLoS One 8:e58071. doi: 10.1371\/journal.pone.0058071","journal-title":"PLoS One"},{"key":"3814_CR3","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4254\/wjh.v5.i4.214","volume":"5","author":"SN Wong","year":"2013","unstructured":"Wong SN, Ong JP, Labio ME, Cabahug OT, Daez ML, Valdellon EV, Sollano JD Jr, Arguillas MO (2013) Hepatitis B infection among adults in the Philippines: a national seroprevalence study. World J Hepatol 5:214\u2013219. doi: 10.4254\/wjh.v5.i4.214","journal-title":"World J Hepatol"},{"key":"3814_CR4","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/j.1478-3231.2011.02507.x","volume":"31","author":"W Li","year":"2011","unstructured":"Li W, Jiang Y, Jin Q, Shi X, Jin J, Gao Y, Pan Y, Zhang H, Jiang J, Niu J (2011) Expression and gene polymorphisms of interleukin 28B and hepatitis B virus infection in a Chinese Han population. Liver Int 31:1118\u20131126. doi: 10.1111\/j.1478-3231.2011.02507.x","journal-title":"Liver Int"},{"key":"3814_CR5","doi-asserted-by":"crossref","first-page":"e50787","DOI":"10.1371\/journal.pone.0050787","volume":"7","author":"J Chen","year":"2012","unstructured":"Chen J, Wang L, Li Y, Cai B, Fu Y, Liao Y, Zhang J (2012) Association analysis between SNPs in IL28B gene and the progress of hepatitis B infection in Han Chinese. PLoS One 7:e50787. doi: 10.1371\/journal.pone.0050787","journal-title":"PLoS One"},{"key":"3814_CR6","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/jmv.23207","volume":"84","author":"K Hayashi","year":"2012","unstructured":"Hayashi K, Katano Y, Kuzuya T, Tachi Y, Honda T, Ishigami M, Itoh A, Hirooka Y, Ishikawa T, Nakano I, Urano F, Yoshioka K, Toyoda H, Kumada T, Goto H (2012) Prevalence of hepatitis C virus genotype 1a in Japan and correlation of mutations in the NS5A region and single nucleotide polymorphism of interleukin 28B with the response to combination therapy with pegylated-interferon-alpha 2b and ribavirin. J Med Virol 84:438\u2013444. doi: 10.1002\/jmv.23207","journal-title":"J Med Virol"},{"key":"3814_CR7","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1007\/s00262-012-1203-y","volume":"61","author":"S Ren","year":"2012","unstructured":"Ren S, Lu J, Du X, Huang Y, Ma L, Huo H, Chen X, Wei L (2012) Genetic variation in IL28B is associated with the development of hepatitis B-related hepatocellular carcinoma. Cancer Immunol Immunother 61:1433\u20131439. doi: 10.1007\/s00262-012-1203-y","journal-title":"Cancer Immunol Immunother"},{"key":"3814_CR8","doi-asserted-by":"crossref","first-page":"e69166","DOI":"10.1371\/journal.pone.0069166","volume":"8","author":"SU Kim","year":"2013","unstructured":"Kim SU, Song KJ, Chang HY, Shin EC, Park JY, Kim Do Y, Han KH, Chon CY, Ahn SH (2013) Association between IL28B polymorphisms and spontaneous clearance of hepatitis B virus infection. PLoS One 8:e69166. doi: 10.1371\/journal.pone.0069166","journal-title":"PLoS One"},{"key":"3814_CR9","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/apt.12631","volume":"39","author":"E Galmozzi","year":"2014","unstructured":"Galmozzi E, Vigan\u00f2 M, Lampertico P (2014) Systematic review with meta-analysis: do interferon lambda 3 polymorphisms predict the outcome of interferon-therapy in hepatitis B infection? Aliment Pharmacol Ther 39:569\u2013578. doi: 10.1111\/apt.12631","journal-title":"Aliment Pharmacol Ther"},{"key":"3814_CR10","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","volume":"461","author":"D Ge","year":"2009","unstructured":"Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, Heinzen EL, Qiu P, Bertelsen AH, Muir AJ, Sulkowski M, McHutchison JG, Goldstein DB (2009) Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461:399\u2013401. doi: 10.1038\/nature08309","journal-title":"Nature"},{"key":"3814_CR11","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/ng.447","volume":"41","author":"V Suppiah","year":"2009","unstructured":"Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, Abate ML, Bassendine M, Spengler U, Dore GJ, Powell E, Riordan S, Sheridan D, Smedile A, Fragomeli V, M\u00fcller T, Bahlo M, Stewart GJ, Booth DR, George J (2009) IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet 41:1100\u20131104. doi: 10.1038\/ng.447","journal-title":"Nat Genet"},{"key":"3814_CR12","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ng.449","volume":"41","author":"Y Tanaka","year":"2009","unstructured":"Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, Sakamoto N, Nakagawa M, Korenaga M, Hino K, Hige S, Ito Y, Mita E, Tanaka E, Mochida S, Murawaki Y, Honda M, Sakai A, Hiasa Y, Nishiguchi S, Koike A, Sakaida I, Imamura M, Ito K, Yano K, Masaki N, Sugauchi F, Izumi N, Tokunaga K, Mizokami M (2009) Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet 41:1105\u20131109. doi: 10.1038\/ng.449","journal-title":"Nat Genet"},{"key":"3814_CR13","doi-asserted-by":"crossref","first-page":"e77911","DOI":"10.1371\/journal.pone.0077911","volume":"8","author":"X Guo","year":"2013","unstructured":"Guo X, Yang G, Yuan J, Ruan P, Zhang M, Chen X, Zhou B (2013) Genetic variation in interleukin 28B and response to antiviral therapy in patients with dual chronic infection with hepatitis B and C viruses. PLoS One 8:e77911. doi: 10.1371\/journal.pone.0077911","journal-title":"PLoS One"},{"key":"3814_CR14","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1086\/657146","volume":"202","author":"MP Martin","year":"2010","unstructured":"Martin MP, Qi Y, Goedert JJ, Hussain SK, Kirk GD, Hoots WK, Buchbinder S, Carrington M, Thio CL (2010) IL28B polymorphism does not determine outcomes of hepatitis B virus or HIV infection. J Infect Dis 202:1749\u20131753. doi: 10.1086\/657146","journal-title":"J Infect Dis"},{"key":"3814_CR15","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1399-0039.2011.01835.x","volume":"79","author":"LJ Peng","year":"2012","unstructured":"Peng LJ, Guo JS, Zhang Z, Shi H, Wang J, Wang JY (2012) IL28B rs12979860 polymorphism does not influence outcomes of hepatitis B virus infection. Tissue Antigens 79:302\u2013305. doi: 10.1111\/j.1399-0039.2011.01835.x","journal-title":"Tissue Antigens"},{"key":"3814_CR16","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/jgh.12110","volume":"28","author":"JA Holmes","year":"2013","unstructured":"Holmes JA, Nguyen T, Ratnam D, Heerasing NM, Tehan JV, Bonanzinga S, Dev A, Bell S, Pianko S, Chen R, Visvanathan K, Hammond R, Iser D, Rusli F, Sievert W, Desmond PV, Bowden DS, Thompson AJ (2013) IL28B genotype is not useful for predicting treatment outcome in Asian chronic hepatitis B patients treated with pegylated interferon-\u03b1. J Gastroenterol Hepatol 28:861\u2013866. doi: 10.1111\/jgh.12110","journal-title":"J Gastroenterol Hepatol"},{"key":"3814_CR17","doi-asserted-by":"crossref","first-page":"6189","DOI":"10.1007\/s11033-013-2730-0","volume":"40","author":"\u00d6 Kandemir","year":"2013","unstructured":"Kandemir \u00d6, Fidanc\u0131 SB, Demir N, G\u00f6r\u00fcr A, Tamer L (2013) Chronic hepatitis B and IL28B rs12979860 polymorphism: preliminary study. Mol Biol Rep 40:6189\u20136194. doi: 10.1007\/s11033-013-2730-0","journal-title":"Mol Biol Rep"},{"key":"3814_CR18","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000342526","volume":"56","author":"DH Lee","year":"2013","unstructured":"Lee DH, Cho Y, Seo JY, Kwon JH, Cho EJ, Jang ES, Kwak MS, Cheong JY, Cho SW, Lee JH, Yu SJ, Yoon JH, Lee HS, Kim CY, Shin HD, Kim YJ (2013) Polymorphisms near interleukin 28B gene are not associated with hepatitis B virus clearance, hepatitis B e antigen clearance and hepatocellular carcinoma occurrence. Intervirology 56:84\u201390. doi: 10.1159\/000342526","journal-title":"Intervirology"},{"key":"3814_CR19","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature08463","volume":"461","author":"DL Thomas","year":"2009","unstructured":"Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O\u2019Huigin C, Kidd J, Kidd K, Khakoo SI, Alexander G, Goedert JJ, Kirk GD, Donfield SM, Rosen HR, Tobler LH, Busch MP, McHutchison JG, Goldstein DB, Carrington M (2009) Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461:798\u2013801. doi: 10.1038\/nature08463","journal-title":"Nature"},{"key":"3814_CR20","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nrgastro.2012.101","volume":"9","author":"CN Hayes","year":"2012","unstructured":"Hayes CN, Imamura M, Aikata H, Chayama K (2012) Genetics of IL28B and HCV response to infection and treatment. Nat Rev Gastroenterol Hepatol 9:406\u2013417. doi: 10.1038\/nrgastro.2012.101","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3814_CR21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1479-5876-10-25","volume":"10","author":"ZM Younossi","year":"2012","unstructured":"Younossi ZM, Birerdinc A, Estep M, Stepanova M, Afendy A, Baranova A (2012) The impact of IL28B genotype on the gene expression profile of patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin. J Transl Med 10:25. doi: 10.1186\/1479-5876-10-25","journal-title":"J Transl Med"},{"key":"3814_CR22","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.3748\/wjg.v10.i21.3132","volume":"10","author":"GB Zeng","year":"2004","unstructured":"Zeng GB, Wen SJ, Wang ZH, Yan L, Sun J, Hou JL (2004) A novel hepatitis B virus genotyping system by using restriction fragment length polymorphism patterns of S gene amplicons. World J Gastroenterol 10:3132\u20133136","journal-title":"World J Gastroenterol"},{"key":"3814_CR23","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/jmv.23717","volume":"86","author":"MO Baclig","year":"2014","unstructured":"Baclig MO, Alvarez MR, Gopez-Cervantes J, Natividad FF (2014) Unique surface gene variants of hepatitis B virus isolated from patients in the Philippines. J Med Virol 86:209\u2013216. doi: 10.1002\/jmv.23717","journal-title":"J Med Virol"},{"key":"3814_CR24","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jhep.2010.07.019","volume":"54","author":"C Fabris","year":"2011","unstructured":"Fabris C, Falleti E, Cussigh A, Bitetto D, Fontanini E, Bignulin S, Cmet S, Fornasiere E, Fumolo E, Fangazio S, Cerutti A, Minisini R, Pirisi M, Toniutto P (2011) IL-28B rs12979860 C\/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC. J Hepatol 54:716\u2013722. doi: 10.1016\/j.jhep.2010.07.019","journal-title":"J Hepatol"},{"key":"3814_CR25","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/aje\/kwn359","volume":"169","author":"S Rodriguez","year":"2009","unstructured":"Rodriguez S, Gaunt TR, Day INM (2009) Hardy-Weinberg Equilibrium testing of biological ascertainment for Mendelian randomization studies. Am J Epidemiol 169:505\u2013514. doi: 10.1093\/aje\/kwn359","journal-title":"Am J Epidemiol"},{"key":"3814_CR26","author":"S Akkarathamrongsin","year":"2014","unstructured":"Akkarathamrongsin S, Thong VD, Payungporn S, Poovorawan K, Prapunwattana P, Poovorawan Y, Tangkijvanich P (2014) IFNL3 (IL28B) and IFNL4 polymorphisms are associated with treatment response in Thai patients infected with HCV genotype 1, but not with genotypes 3 and 6. J Med Virol. doi: 10.1002\/jmv.23957","journal-title":"J Med Virol"},{"key":"3814_CR27","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00251-013-0688-7","volume":"65","author":"JF G\u00e9linas","year":"2013","unstructured":"G\u00e9linas JF, Fabre T, Willems P, Leung RC, George J, Willems B, Bruneau J, Shoukry NH (2013) IL28B SNP screening and distribution in the French Canadian population using a rapid PCR-based test. Immunogenetics 65:397\u2013403. doi: 10.1007\/s00251-013-0688-7","journal-title":"Immunogenetics"},{"key":"3814_CR28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/hep.23624","volume":"52","author":"MA Montes-Cano","year":"2010","unstructured":"Montes-Cano MA, Garc\u00eda-Lozano JR, Abad-Molina C, Romero-G\u00f3mez M, Barroso N, Aguilar-Reina J, N\u00fa\u00f1ez-Rold\u00e1n A, Gonz\u00e1lez-Escribano MF (2010) Interleukin-28B genetic variants and hepatitis virus infection by different viral genotypes. Hepatology 52:33\u201337. doi: 10.1002\/hep.23624","journal-title":"Hepatology"},{"key":"3814_CR29","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/jgh.12424","volume":"29","author":"SK Roberts","year":"2014","unstructured":"Roberts SK, Mitchell J, Leung R, Booth D, Bollipo S, Ostapowicz G, Sloss A, McCaughan GW, Dore GJ, Thompson A, Crawford DH, Sievert W, Weltman M, Cheng W, George J, Network Australian Liver Association Clinical Research (2014) Distribution of interferon lambda-3 gene polymorphisms in Australian patients with previously untreated genotype 1 chronic hepatitis C: analysis from the PREDICT and CHARIOT studies. J Gastroenterol Hepatol 29:179\u2013184. doi: 10.1111\/jgh.12424","journal-title":"J Gastroenterol Hepatol"},{"key":"3814_CR30","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/jmv.2065","volume":"65","author":"P Kimball","year":"2001","unstructured":"Kimball P, Elswick RK, Shiffman M (2001) Ethnicity and cytokine production gauge response of patients with hepatitis C to interferon-alpha therapy. J Med Virol 65:510\u2013516","journal-title":"J Med Virol"},{"key":"3814_CR31","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jviromet.2012.05.024","volume":"184","author":"S Moreira","year":"2012","unstructured":"Moreira S, Garcia RFL, Gutberlet A, Bertol BC, Ferreira LE, de Souza Leite Pinho M, de Fran\u00e7a PHC (2012) A straightforward genotyping of the relevant IL28B SNPs for the prediction of hepatitis C treatment outcome. J Virol Methods 184:93\u201397. doi: 10.1016\/j.jviromet.2012.05.024","journal-title":"J Virol Methods"},{"key":"3814_CR32","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jcv.2013.08.010","volume":"58","author":"M Martinot-Peignoux","year":"2013","unstructured":"Martinot-Peignoux M, Lapalus M, Laou\u00e9nan C, Lada O, Netto-Cardoso AC, Boyer N, Ripault MP, Carvalho-Filho R, Asselah T, Marcellin P (2013) Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA. J Clin Virol 58:401\u2013417. doi: 10.1016\/j.jcv.2013.08.010","journal-title":"J Clin Virol"},{"key":"3814_CR33","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1128\/JCM.00877-11","volume":"49","author":"S Fonseca-Coronado","year":"2011","unstructured":"Fonseca-Coronado S, Vaughan G, Cruz-Rivera MY, Carpio-Pedroza JC, Ruiz-Tovar K, Ruiz-Pacheco JA, Escobar-Guti\u00e9rrez A (2011) Interleukin-28B genotyping by melt-mismatch amplification mutation assay PCR analysis using single nucleotide polymorphisms rs12979860 and rs8099917 a useful tool for prediction of therapy response in hepatitis C patients. Clin Microbiol 49:2706\u20132710. doi: 10.1128\/JCM.00877-11","journal-title":"Clin Microbiol"},{"key":"3814_CR34","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.antiviral.2011.12.009","volume":"93","author":"X Wu","year":"2012","unstructured":"Wu X, Xin Z, Zhu X, Pan L, Li Z, Li H, Liu Y (2012) Evaluation of susceptibility locus for response to interferon-\u03b1 based therapy in chronic hepatitis B patients in Chinese. Antiviral Res 93:297\u2013300. doi: 10.1016\/j.antiviral.2011.12.009","journal-title":"Antiviral Res"},{"key":"3814_CR35","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1348-0421.2012.00439.x","volume":"56","author":"S Kani","year":"2012","unstructured":"Kani S, Tanaka Y, Matsuura K, Watanabe T, Yatsuhashi H, Orito E, Inose K, Motojuku N, Wakimoto Y, Mizokami M (2012) Development of new IL28B genotyping method using Invader Plus assay. Microbiol Immunol 56:318\u2013323. doi: 10.1111\/j.1348-0421.2012.00439.x","journal-title":"Microbiol Immunol"},{"key":"3814_CR36","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/jgh.12398","volume":"29","author":"H Rao","year":"2014","unstructured":"Rao H, Wei L, Lopez-Talavera JC, Shang J, Chen H, Li J, Xie Q, Gao Z, Wang L, Wei J, Jiang J, Sun Y, Yang R, Li H, Zhang H, Gong Z, Zhang L, Zhao L, Dou X, Niu J, You H, Chen Z, Ning Q, Gong G, Wu S, Ji W, Mao Q, Tang H, Li S, Wei S, Sun J, Jiang J, Lu L, Jia J, Zhuang H (2014) Distribution and clinical correlates of viral and host genotypes in Chinese patients with chronic hepatitis C virus infection. J Gastroenterol Hepatol 29:545\u2013553. doi: 10.1111\/jgh.12398","journal-title":"J Gastroenterol Hepatol"},{"key":"3814_CR37","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/apt.12717","volume":"39","author":"AF St\u00e4ttermayer","year":"2014","unstructured":"St\u00e4ttermayer AF, Scherzer T, Beinhardt S, Rutter K, Hofer H, Ferenci P (2014) Review article: genetic factors that modify the outcome of viral hepatitis. Aliment Pharmacol Ther 39:1059\u20131070. doi: 10.1111\/apt.12717","journal-title":"Aliment Pharmacol Ther"},{"key":"3814_CR38","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jhep.2013.09.023","volume":"60","author":"ML Yu","year":"2014","unstructured":"Yu ML, Dai CY, Huang CF, Lee JJ, Yeh ML, Yeh SM, Kuo HT, Huang JF, Chang JM, Chen HC, Juo SH, Hwang SJ, Chuang WL, FORMOSA-LIKE group (2014) High hepatitis B virus surface antigen levels and favorable interleukin 28B genotype predict spontaneous hepatitis C virus clearance in uremic patients. J Hepatol 60:253\u2013259. doi: 10.1016\/j.jhep.2013.09.023","journal-title":"J Hepatol"},{"key":"3814_CR39","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1053\/j.gastro.2011.11.025","volume":"142","author":"MJ Sonneveld","year":"2012","unstructured":"Sonneveld MJ, Wong VW, Woltman AM, Wong GL, Cakaloglu Y, Zeuzem S, Buster EH, Uitterlinden AG, Hansen BE, Chan HL, Janssen HL (2012) Polymorphisms near IL28B and serologic response to peginterferon in HBeAg-positive patients with chronic hepatitis B. Gastroenterology 142:513\u2013520. doi: 10.1053\/j.gastro.2011.11.025","journal-title":"Gastroenterology"},{"key":"3814_CR40","author":"AA Al-Qahtani","year":"2013","unstructured":"Al-Qahtani AA, Al-Anazi MR, Abdo AA, Sanai FM, Al-Hamoudi WK, Alswat KA, Al-Ashgar HI, Khalaf NZ, Viswan NA, Al Ahdal MN (2013) Genetic variation in interleukin 28B and correlation with chronic hepatitis B virus infection in Saudi Arabian patients. Liver Int. doi: 10.1111\/liv.12347","journal-title":"Liver Int"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-014-3814-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-014-3814-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-014-3814-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T10:58:37Z","timestamp":1566039517000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-014-3814-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,13]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["3814"],"URL":"https:\/\/doi.org\/10.1007\/s11033-014-3814-1","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2014,11,13]]}}}